This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
The recent report of Parrish et al on facial irritation in the April issue of the Archives (111:525, 1975) is at complete variance with our widespread experience with Eclipse. Since March of 1974, over 500,000 units have been distributed with a 0.02% incidence of facial problems. These reports range from mild, transient stinging to a few cases of apparent contact sensitivity, a phenomenon known to occur with sunscreens containing aminobenzoic acid and its derivatives in a small percentage of the population.Although numerous prophetic tests are accomplished prior to introduction of any product, the most rigorous test is that of wide clinical acceptance. Eclipse has passed this test in our judgment.
Wilson JW. Staphylococcal Toxic Epidermal Necrolysis-Reply to Drs. Parrish, Pathak, and Fitzpatrick. Arch Dermatol. 1975;111(8):1074. doi:10.1001/archderm.1975.01630200134032